UB Paderborn / Katalog / Suche / in CDI

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

The Lancet (British edition), 2016-01, Vol.387 (10013), p.53-60

2016

Volltextzugriff (PDF)

Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions

AIDS (London), 2014-08, Vol.28 (13), p.1967-1975

2014

Volltextzugriff (PDF)

HIV-1 Subtype and Virological Response to Antiretroviral Therapy: A Confirmatory Analysis

Clinical infectious diseases, 2013-01, Vol.56 (1), p.162-163

2013

Volltextzugriff (PDF)

The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data

BMC infectious diseases, 2017-02, Vol.17 (1), p.160-160, Article 160

2017

Volltextzugriff (PDF)

Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial

Sexually transmitted infections, 2019-09, Vol.95 (6), p.449

2019

Volltextzugriff (PDF)

An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis

Trials, 2016-03, Vol.17 (1), p.163, Article 163

2016

Volltextzugriff (PDF)

The increasing genetic diversity of HIV-1 in the UK, 2002―2010

AIDS (London), 2014-03, Vol.28 (5), p.773-780

Anon

2014

Volltextzugriff (PDF)

Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D

PloS one, 2014-01, Vol.9 (1), p.e83337-e83337

2014

Volltextzugriff (PDF)

Intercontinental dispersal of HIV-1 subtype B associated with transmission among men who have sex with men in Japan

Journal of virology, 2014-09, Vol.88 (17), p.9864-9876

2014

Volltextzugriff (PDF)

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults

AIDS (London), 2013-09, Vol.27 (14), p.2245-2253

2013

Volltextzugriff (PDF)

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study

Journal of antimicrobial chemotherapy, 2013-10, Vol.68 (10), p.2339-2343

2013

Volltextzugriff (PDF)

Subtype-specific differences in the development of accessory mutations associated with high-level resistance to HIV-1 nucleoside reverse transcriptase inhibitors

Journal of antimicrobial chemotherapy, 2013-06, Vol.68 (6), p.1220-1236

2013

Volltextzugriff (PDF)

Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study

Journal of antimicrobial chemotherapy, 2011-08, Vol.66 (8), p.1886-1896

2011

Volltextzugriff (PDF)

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor

Journal of antimicrobial chemotherapy, 2012-04, Vol.67 (4), p.995-1000

2012

Volltextzugriff (PDF)

Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study

BMJ (Online), 2012-08, Vol.345, p.e5253

2012

Volltextzugriff (PDF)

The prevalence of darunavir―associated mutations in HIV―1―infected children in the UK

Antiviral therapy, 2012-01, Vol.17 (4), p.599-603

2012

Volltextzugriff (PDF)

Fifty Years of Shock-Wave/Boundary-Layer Interaction Research: What Next?

AIAA journal, 2001-08, Vol.39 (8), p.1517-1531

Dolling, David S

2001

Volltextzugriff (PDF)

Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer

European urology, 2019-10, Vol.76 (4), p.469-478

2019

Volltextzugriff (PDF)

Predicting farmer uptake of new agricultural practices: A tool for research, extension and policy

Agricultural systems, 2017-09, Vol.156, p.115-125

2017

Volltextzugriff (PDF)

Genomics of lethal prostate cancer at diagnosis and castration resistance

The Journal of clinical investigation, 2020-04, Vol.130 (4), p.1743-1751

2020

Volltextzugriff (PDF)

Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)

European urology, 2018-09, Vol.74 (3), p.283-291

2018

Volltextzugriff (PDF)

Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)

Clinical cancer research, 2018-07, Vol.24 (13), p.3149-3162

2018

Volltextzugriff (PDF)

Artificial gravity partially protects space-induced neurological deficits in Drosophila melanogaster

Cell reports (Cambridge), 2022-09, Vol.40 (10), p.111279-111279, Article 111279

2022

Volltextzugriff (PDF)

Physics of unsteady cylinder-induced shock-wave/transitional boundary-layer interactions

Journal of fluid mechanics, 2021-07, Vol.918, Article A39

2021

Volltextzugriff (PDF)

Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

The Lancet (British edition), 2020-04, Vol.395 (10232), p.1268-1277

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions

HIV-1 Subtype and Virological Response to Antiretroviral Therapy: A Confirmatory Analysis

The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data

Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial

An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis

The increasing genetic diversity of HIV-1 in the UK, 2002―2010

Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D

Intercontinental dispersal of HIV-1 subtype B associated with transmission among men who have sex with men in Japan

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study

Subtype-specific differences in the development of accessory mutations associated with high-level resistance to HIV-1 nucleoside reverse transcriptase inhibitors

Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study

Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor

Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study

The prevalence of darunavir―associated mutations in HIV―1―infected children in the UK

Fifty Years of Shock-Wave/Boundary-Layer Interaction Research: What Next?

Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer

Predicting farmer uptake of new agricultural practices: A tool for research, extension and policy

Genomics of lethal prostate cancer at diagnosis and castration resistance

Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA)

Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)

Artificial gravity partially protects space-induced neurological deficits in Drosophila melanogaster

Physics of unsteady cylinder-induced shock-wave/transitional boundary-layer interactions

Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

Suchergebnisse filtern